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Response to Letter to the Editor by Robert Martindale 
 
To the editorial board of Journal of Trauma  
 
We acknowledge the critizism raised by this author.  
 
The patients included in the current study all underwent open emergency abdominal surgery (1). 
Such patients are not treated with a minimal invasive approach and the abdominal wall is entered 
through a midline laparotomy. Thus, incision size as a confounding factor is unlikely. Wound 
issues are reported in Table 2 as surgical site infections. Duration of operation and previous 
abdominal surgery are reported in Table 1. Regarding the experience of the surgeons who 
performed the emergency abdominal procedures, we kindly refer to our last response to the letter 
to the editor by Dr. Gachabayov. Intra-abdominal mesh placement is routinely performed both, 
in emergency and elective procedures at the Bern University Hospital. The implantation of intra-
abdominal meshes has not been shown to be associated with specific complications in previous 
studies published by our department (2-6). 
 
The results clearly reveal the potential hazards associated with biologic mesh implantation in the 
infected abdominal cavity. The letter of Dr. Martindale refers to retrospective studies with 
known selection biases whereas our study was a propective randomized-controlled clinical trial. 
It is of importance to note that the studied cohort consists of patients with acutely inflamed and 
infected abdomen which is not present in elective or emergency hernia repair. The Strattice mesh 
seem not to fit the needs for such challenging situations. We acknowledge that the current study 
is indeed limited by its sample size to make conclusions about the primary endpoint. However, 
continuing such a study would not have been in line with good clinical practice guidelines 






because of ethical concerns in the light of the observed complications.  
 
In our experience, synthetic mesh implantation in patients undergoing emergency abdominal 
surgery leads to an important foreign body reaction and scarring about two weeks after synthetic 
mesh implantation. Because of the reported properties of biologic meshes, potentially this 
reaction seems to be delayed. The situation as observed in the patient in fig. 2 has not been 
observed upon synthetic mesh placement at our department. The patient in fig. 3 had a nearly 
complete loss of the mesh and intestinal contents were visible. The adhesion formation per se 
was not the main issue in the situation shown in fig. 4 but rather the mesh infection. 
 
As shown in table 2 of the article, abdominal wall complications were frequent in both groups 
and not statistically different (p=1.000). However, within the group of patients with abdominal 
wall complications (denominator), serious complications requiring revisional surgery were 
significantly more frequent in the mesh group.  
 
In our study, the implantation of expensive biologic Strattice meshes were associated with 
increased direct costs for the mesh and indirect costs because of complications. Taking into 
account the significant increase in serious abdominal wall complications already after inclusion 
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